Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The list is longer than the time I bot in.
Some volume recently. They need to move the stock to Amex or Nasdaq.
Looks like someone is shorting it. They will regret later
Chart is beautiful
I do not think Sian is helping. Just let Frost do his thing
OPK is again going to worth what it is for BRL only!
"BCX9930 will make C-5 inhibitors obsolete" Bill Sheridan. That is north of $ 50b per year!
Herself was paid a chunk of stocks at 1.2c for two years of work before rs.
Finally. I remember game was the one first to spot the Mobile service BRL is going to offer https://www.opko.com/news-media/press-releases/detail/419/opko-healths-bioreference-laboratories-introduces-scarlet
Orladeyo launch updates throughout the year!
Upgrade BCRX! Jesse from JPM https://www.tipranks.com/analysts/jessica-fye
Launch updates throughout the year!
Shorts are covering. They know it is game over for them! 12/31/2020 30,945,985 7,303,357 4.237227
Shorts are covering. They know it is game over for them! 12/31/2020 115,230,234 7,798,680 14.775607
It is happening. I hope it is a crypto company!
Authorized Shares
2,000,000,000
01/12/2021
Outstanding Shares
914,788
01/12/2021
Restricted
878,539
01/12/2021
Unrestricted
36,249
01/12/2021
Let them dilute. The important thing is to have the mine up running. They already have all the tailwinds
Interesting to see C-Reveal is going to the JPM conference to which SRNE is not invited.
JPM upgrades tomorrow!
Someone is loading
Might see an upgrade from JPM. That for sure should squeeze some shorts out
I took the last 8k a good sign
Interesting volume!
Short interest data tomorrow
SOLIRIS® (eculizumab) net product sales were $3,946.4 million , compared to $3,563.0 million in 2018, representing an 11 percent increase.Jan 30, 2020
BCRX will sit at $30b market cap one day!
More to come. The cost for PNH C5 inhibitor Ravulizumab provided lifetime per-patient cost reductions (discounted) of 32.4% and 35.5% vs eculizumab in adult and pediatric base cases, respectively. Total costs for ravulizumab vs eculizumab were $12,148,748 and $17,979,007, respectively, for adults, and $11,587,832 and $17,959,814, respectively, for children.
https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1831519#:~:text=Ravulizumab%20provided%20lifetime%20per%2Dpatient,%2417%2C959%2C814%2C%20respectively%2C%20for%20children.
More testing! South Africa variant E484K mutation disables Pfizer vaccine and polyclonal antibodies
1/📌Concerning case of reinfection: healthy 45 year old was reinfected with the genetically distinct SARS-CoV-2 variant that harbors the E484K mutation - this is the variant that was recently reported to escape neutralizing antibodies 1/6🧵 pic.twitter.com/h83eqc0sO8
— Dr. Ali Nouri (@AliNouriPhD) January 7, 2021
Taking Orladeyo! Lil HAE vlog & Unboxing https://t.co/ieKPYBMjAd via @YouTube making history @MakanaR so happy for you!!! A moment in HAE history. Just wow! What a difference a pill makes. For the 1st time I didn’t cringe from HAE pt video taking their meds thanx @BioCrystPharma
— R8Plus (@AAABiotech) January 9, 2021
Thanks. Make sense. Carole is a better choice for the position. "Kathryn Kraysler is the sister of the Company’s Chief Financial Officer"
SEC Will Raise Reg CF Limit to $5M
https://ragingbull.com/angel-insights/sec-will-raise-reg-cf-limit-to-5m/
The second change actually looks more important to me. You do not need to calculate the ceiling for your annual REG CF investment
Why do they need to 8k Carol's agreement? Does she only work for shares? That is interesting!
Carol has a very neat hobby website http://heirloommeals.com/
NFL testing on NPR right now